Mazzeschi, Martina; Sgarzi, Michela; Romaniello, Donatella; Gelfo, Valerio; Cavallo, Carola; Ambrosi, Francesca; Morselli, Alessandra; Miano, Carmen; Laprovitera, Noemi; Girone, Cinzia; Ferracin, Manuela; Santi, Spartaco; Rihawi, Karim; Ardizzoni, Andrea; Fiorentino, Michelangelo; D'Uva, Gabriele; Győrffy, Balázs; Palmer, Ruth; Lauriola, Mattia, The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2022, 41, pp. 113 - 131 [articolo]Open Access
Maranini B.; Ciancio G.; Ferracin M.; Cultrera R.; Negrini M.; Sabbioni S.; Govoni M., microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review, «LIFE», 2022, 12, Article number: 288, pp. 1 - 17 [articolo]Open Access
Laprovitera N.; Riefolo M.; Ambrosini E.; Klec C.; Pichler M.; Ferracin M., Cancer of unknown primary: Challenges and progress in clinical management, «CANCERS», 2021, 13, Article number: 451, pp. 1 - 29 [articolo]Open Access
Salamon I.; Biagini E.; Kunderfranco P.; Roncarati R.; Ferracin M.; Taglieri N.; Nardi E.; Laprovitera N.; Tomasi L.; Santostefano M.; Ditaranto R.; Vitale G.; Cavarretta E.; Pisani A.; Riccio E.; Aiello V.; Capelli I.; La Manna G.; Galie N.; Spinelli L.; Condorelli G., Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease, «CELL DEATH & DISEASE», 2021, 12, Article number: 1150, pp. 1 - 7 [articolo]Open Access
Dika E.; Patrizi A.; Rossi C.; Turchetti D.; Miccoli S.; Ferracin M.; Veronesi G.; Scarfi F.; Lambertini M., Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic, «ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY», 2021, 156, pp. 599 - 605 [articolo]
Sabbatinelli J.; Giuliani A.; Matacchione G.; Latini S.; Laprovitera N.; Pomponio G.; Ferrarini A.; Svegliati Baroni S.; Pavani M.; Moretti M.; Gabrielli A.; Procopio A.D.; Ferracin M.; Bonafè M.; Olivieri F., Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients, «MECHANISMS OF AGEING AND DEVELOPMENT», 2021, 193, Article number: 111413, pp. 1 - 6 [articolo]
Laprovitera N.; Salamon I.; Gelsomino F.; Porcellini E.; Riefolo M.; Garonzi M.; Tononi P.; Valente S.; Sabbioni S.; Fontana F.; Manaresi N.; D'Errico A.; Pantaleo M.A.; Ardizzoni A.; Ferracin M., Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches, «FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY», 2021, 9, Article number: 666156, pp. 1 - 15 [articolo]Open Access
Manganelli M.; Grossi I.; Ferracin M.; Guerriero P.; Negrini M.; Ghidini M.; Senti C.; Ratti M.; Pizzo C.; Passalacqua R.; Molfino S.; Baiocchi G.; Portolani N.; Marchina E.; De Petro G.; Salvi A., Longitudinal circulating levels of mir-23b-3p, mir-126-3p and lncrna gas5 in hcc patients treated with sorafenib, «BIOMEDICINES», 2021, 9, Article number: 813, pp. 1 - 12 [articolo]Open Access
Laprovitera N.; Riefolo M.; Porcellini E.; Durante G.; Garajova I.; Vasuri F.; Aigelsreiter A.; Dandachi N.; Benvenuto G.; Agostinis F.; Sabbioni S.; Berindan Neagoe I.; Romualdi C.; Ardizzoni A.; Trere' D.; Pichler M.; D'Errico A.; Ferracin M., MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary, «MOLECULAR ONCOLOGY», 2021, 15, pp. 2732 - 2751 [articolo]Open Access
Broseghini E.; Dika E.; Londin E.; Ferracin M., Microrna isoforms contribution to melanoma pathogenesis, «NON-CODING RNA», 2021, 7, Article number: 63, pp. 1 - 27 [articolo]Open Access
Sapienza M.R.; Benvenuto G.; Ferracin M.; Mazzara S.; Fuligni F.; Tripodo C.; Belmonte B.; Fanoni D.; Melle F.; Motta G.; Tabanelli V.; Consiglio J.; Mazzara V.; Corvo M.D.; Fiori S.; Pileri A.; Dellino G.I.; Cerroni L.; Facchetti F.; Berti E.; Sabattini E.; Paulli M.; Croce C.M.; Pileri S.A., Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm, «CANCERS», 2021, 13, Article number: 4680, pp. 4680 - 4680 [articolo]Open Access
Durante G.; Comito F.; Lambertini M.; Broseghini E.; Dika E.; Ferracin M., Non-coding RNA dysregulation in skin cancers, «ESSAYS IN BIOCHEMISTRY», 2021, 65, pp. 641 - 655 [articolo]
Pegoraro A.; De Marchi E.; Ferracin M.; Orioli E.; Zanoni M.; Bassi C.; Tesei A.; Capece M.; Dika E.; Negrini M.; Di Virgilio F.; Adinolfi E., P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells, «CELL DEATH & DISEASE», 2021, 12, Article number: 1088, pp. 1 - 12 [articolo]Open Access
Pilli T.; Cardinale S.; Cantara S.; Dalmazio G.; Forleo R.; Capezzone M.; Bassi C.; Negrini M.; Ferracin M.; Castagna M.G., Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone, «ENDOCRINE», 2021, 73, pp. 177 - 185 [articolo]
Dika E.; Broseghini E.; Porcellini E.; Lambertini M.; Riefolo M.; Durante G.; Loher P.; Roncarati R.; Bassi C.; Misciali C.; Negrini M.; Rigoutsos I.; Londin E.; Patrizi A.; Ferracin M., Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis, «CELL DEATH & DISEASE», 2021, 12, Article number: 473, pp. 1 - 15 [articolo]Open Access
